Dynasplint Systems
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Dynasplint Systems sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Dynasplint Systems: 9 sponsored US clinical trials, none currently recruiting.
Dynasplint Systems sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hallux Limitus, with 1 trials.
Top-decile sponsor footprint
Dynasplint Systems ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Adhesive Capsulitis and Dynamic Splinting
NCT01874821
Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial
NCT01589679
Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy
NCT01588730
Toe Walker Gait Trial
NCT01208142
Ankle Equinus Contracture Treated With Dynamic Splinting
NCT01238484
Dynamic Splinting After Total Knee Arthroplasty
NCT00857701
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
NCT00717691
Plantar Fasciitis Treated With Dynamic Splinting
NCT00650884
Dynamic Splinting for Patients With Adhesive Capsulitis
NCT00873158
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the Dynasplint Systems archive is shaped
9 indexed studies, none listed as recruiting (0% open); 2 completed (22%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Hallux Limitus (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Dynasplint Systems: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Dynasplint Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Dynasplint Systems page
9 registered trials is a research-attention snapshot, not an endorsement of Dynasplint Systems or any single study.
- None of Dynasplint Systems's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Hallux Limitus is the condition Dynasplint Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hallux Limitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dynasplint Systems pipeline card: 9 registered trials from official public datasets.Report a data error.